Impel Pharmaceuticals Income Tax

Impel Pharmaceuticals (IMPL) currently reports a income tax of $11M as of September 2023. That compares with $2K in the prior-year period — up 549950.0% year over year. Use the charts on this page to explore Impel Pharmaceuticals's income tax history and peer comparisons.

Impel Pharmaceuticals's income tax increased from $2K to $11M — a 549950.0% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Impel Pharmaceuticals reported $11M in income tax as of September 2023. That compares with $2K in the prior-year period — up 549950.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current income tax of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Impel Pharmaceuticals, and consider following IMPL for alerts when major investors trade the stock.

Impel Pharmaceuticals is classified in the Healthcare sector. On income tax, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMPL with unrelated industries.